Adverse drug reactions in hospital in-patients: A pilot study

Journal of Clinical Pharmacy and Therapeutics

Volumn 31, Issue 4, 2006, Pages 335-341

  Davies, E C ^a,c   Green, C F ^b   Mottram, D R ^c   Pirmohamed, M ^a,d  

^a ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b Countess of Chester NHS Foundation Trust ^*  (United Kingdom)

^c LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Adverse drug reactions; Epidemiology; Hospitals

Indexed keywords

ANTIBIOTIC AGENT; ATENOLOL; ATORVASTATIN; BENDROFLUMETHIAZIDE; CEFALEXIN; CIPROFLOXACIN; CISPLATIN; CLOPIDOGREL; COCODAMOL; DICLOFENAC; ENOXAPARIN; FENTANYL; FLUOROURACIL; FLUOXETINE; FUROSEMIDE; IBUPROFEN; ILOPROST; LAXATIVE; METRONIDAZOLE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PERINDOPRIL; PROCYCLIDINE; PROTON PUMP INHIBITOR; SALBUTAMOL; SPIRONOLACTONE; TRAMADOL; UNINDEXED DRUG; VANCOMYCIN;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; BACTERIAL INFECTION; CLOSTRIDIUM DIFFICILE; CONFIDENCE INTERVAL; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG ERUPTION; DRUG INDUCED DISEASE; FEASIBILITY STUDY; FEMALE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HALLUCINATION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPOKALEMIA; HYPOTENSION; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MYOCLONUS; NATIONAL HEALTH SERVICE; OCULOGYRIC CRISIS; PILOT STUDY; RATING SCALE; RECTUM HEMORRHAGE; TENDON REFLEX; TREMOR; UNIVERSITY HOSPITAL; WARD; XEROSTOMIA;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; DRUG THERAPY; FEMALE; GREAT BRITAIN; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PILOT PROJECTS; SEVERITY OF ILLNESS INDEX;

EID: 33745956055     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2006.00744.x     Document Type: Article

References (29)

1. British Broadcasting Corporation. Arthritis drug removed for safety. http://news.bbc.co.uk/1/hi/health/3704640.stm. Accessed 23/01/2006.
2. British Broadcasting Corporation. Seroxat suicides may be more than double that reported to Government regulator. http://www.bbc.co.uk/pressoffice/ pressreleases/stories/2003/05_may/11/panorama_seroxat.shtml. Accessed 23/01/2006.
3. Pirmohamed M, James S, Meakin S et al. (2004) Adverse drug reactions as a cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 329, 15-19.
4. Simmons C, Georgeson EM, Hill RC (1998) Adverse drug reactions: can we reduce the risk? Hospital Pharmacy 33, 1568-1576.
5. Bowman L, Cardstedt BC, Hancock EF, Black CD (1996) Adverse drug reaction (ADR) occurrence and evaluation in elderly in-patients. Pharmacoepidemiology and drug safety 5, 9-18.
6. Wiffen P, Gill M, Edwards J, Moore A (2002) Adverse drug reactions in hospital patients. A systematic review of the prospective and retrospective studies. Bandolier Extra June, 1-16.
7. Edwards IR, Aronson JK (2000) Adverse drug reactions: definitions, diagnosis and management. Lancet 356, 1255-1259.
8. British Medical Association, Royal Pharmaceutical Society of Great Britain. (2005) British National Formulary. London: BMA, RPS, (No 49).
9. Naranjo CA, Busto U, Sellers EM et al. (1981) A method for estimating the probability of adverse drug reactions. Clinical Pharmacology and therapeutics 30, 239-245.
10. Hartwig SC, Siegel J, Schneider PJ (1992) Preventability and severity assessment in reporting adverse drug reactions. American Journal of Hospital Pharmacy 49, 2229-2232.
11. Hallas J, Harvald B, Gram LF, Grodum E, Brosen K, Haghfelt T, Damsbo N (1990) Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. Journal of Internal Medicine 228, 83-90.
12. Medicines and Healthcare Products Regulatory Authority. What to report. http://www.mhra.gov.uk/home/idcplg?IdcService=SS_GET_PAGE&nodeId=750. Accessed 26/01/2006.
13. Rawlins MD, Thompson JW. (1977) Pathogenesis of adverse drug reactions. In: Davies DM, ed. Textbook of Adverse Drug Reactions, Oxford: Oxford University Press, 10.
14. Seidl LG, Thornton GF, Cluff LE (1965) Epidemiological studies of adverse drug reactions. American Journal of Public Health 65, 1170-1175.
15. Smith JW, Seidl LG, Cluff LE (1966) Studies on the epidemiology of adverse drug reactions. V - Clinical factors influencing susceptibility. Annals of Internal Medicine 65, 629-639.
16. Hurwitz N, Wade OL (1969) Intensive hospital monitoring of adverse reactions to drugs. BMJ 1, 531-536.
17. Venulet J, Ten Ham M (1996) Methods for monitoring and documenting adverse drug reactions. International Journal of Clinical Pharmacology and Therapeutics 34, 112-129.
18. Ogilvie RI, Ruedy J (1967) Adverse drug reactions during hospitalization. Canadian Medical Association Journal 97, 1450-1457.
19. Bowman L, Carlstedt BC, Hancock EF, Black CD (1996) Adverse drug reaction (ADR) occurrence and evaluation in elderly in-patients. Pharmacoepidemiology and drug safety 5, 9-18.
20. Evans RS, Pestotnik SL, Classen DC, Horn SD, Bass SB, Burke JP (1994) Preventing adverse drug events in hospitalized patients. Annals of Pharmacotherapy 28, 523-527.
21. Leape LL, Brennan TA, Laird N et al. (1991) The nature of adverse events in hospitalized patients. The New England Journal of Medicine 324, 377-384.
22. Temple ME, Robinson RF, Miller JC, Hayes JR, Nahata MC (2004) Frequency and preventability of adverse drug reactions. Drug Safety 27, 819-829.
23. Gholami K, Shalviri G (1999) Factors associated with preventability, predictability, and severity of adverse drug reactions. Annals of Pharmacotherapy 33, 236-240.
24. Dartnell JGA, Anderson RP, Chohan V, Galbraith KJ, Lyon MEH, Nestor PJ, Moulds RFW (1996) Hospitalisation for adverse events related to drug therapy: incidence, avoidability and costs. The Medical Journal of Australia 164, 659-662.
25. Classen DC, Pestonik SL, Evans RS, Lloyd JF, Burke JP (1997) Adverse drug events in hospitalized patients. JAMA 277, 301-306.
26. Danielson DA, Porter JB, Dinan BJ, O'Connor PC, Lawson DH, Kellaway GSM, Jick H (1982) Drug Monitoring of Surgical Patients. JAMA 248, 1482-1485.
27. Levy MH (1996) Pharmacologic treatment of cancer pain. The New England Journal of Medicine 335, 1124-1133.
28. Moore N, Lecointre D, Noblet C, Mabille M (1998) Frequency and cost of serious adverse drug reactions in a department of general medicine. British Journal of Clinical Pharmacology 45, 301-308.
29. Routledge PA, O'Mahony MS, Woodhouse KW (2003) Adverse drug reactions in elderly patients. British Journal of Clinical Pharmacology 57, 121-126.